Then we have OxyContin ER, which is under review by FDA. So now you have the pipeline populated by something the FDA is reviewing that's going to become in the market.
The settlement was approved by a Federal judge yesterday. New players will soon control the OxyContin market. A settlement with Accord and Elite regarding the patents would seal the deal.
I've told everyone multiple times that the son of a b*tch is trying to sell the company too soon.
In reading the transcript of the call, it reads like Nasrat is confident tht OxyContin ER is coming to the market in the next 6 months, at least it does to me at this moment.